Literature DB >> 17581121

Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function.

J Alfredo Bonilla1, Tonya D Bonilla, Charles A Yowell, Hisashi Fujioka, John B Dame.   

Abstract

Knockout mutants of Plasmodium falciparum lacking pfpm1, pfpm2 and pfhap (triple-PM KO), and mutants lacking all four digestive vacuole (DV) plasmepsins (pfpm4, pfpm1, pfpm2 and pfhap; quadruple-PM KO), were prepared by double cross-over integration effecting chromosomal deletions of up to 14.6 kb. The triple-PM KO was similar to the parental line (3D7) in growth rate, morphology and sensitivity to proteinase inhibitors. The quadruple-PM KO showed a significantly slower rate of growth in standard medium, which manifested as delayed schizont maturation accompanied by reduced formation of haemozoin. In amino acid-limited medium, the reduction in growth rate of the quadruple-PM KO was pronounced. The sensitivity of both the triple- and quadruple-PM KOs to six different HIV aspartic proteinase inhibitors was comparable to that of 3D7, thus establishing that the DV plasmepsins were not the primary targets of the antimalarial activity of these clinically important compounds. Electron microscopic analysis revealed the presence of multilamellar bodies resembling ceroid in the DV of the quadruple-PM KO, and intermediates of the autophagic pathway accumulated as determined by Western blot analysis. Thus, the DV plasmepsins, although not essential, contribute significantly to the fitness of the parasite and are required for efficient degradation of endosomal vesicles delivered to the DV.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581121     DOI: 10.1111/j.1365-2958.2007.05768.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  39 in total

1.  Plasmodium food vacuole plasmepsins are activated by falcipains.

Authors:  Mark E Drew; Ritu Banerjee; Eric W Uffman; Scott Gilbertson; Philip J Rosenthal; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2008-02-28       Impact factor: 5.157

Review 2.  Malaria parasite plasmepsins: More than just plain old degradative pepsins.

Authors:  Armiyaw S Nasamu; Alexander J Polino; Eva S Istvan; Daniel E Goldberg
Journal:  J Biol Chem       Date:  2020-05-04       Impact factor: 5.157

3.  Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum.

Authors:  Monika Chugh; Vidhya Sundararaman; Saravanan Kumar; Vanga S Reddy; Waseem A Siddiqui; Kenneth D Stuart; Pawan Malhotra
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-05       Impact factor: 11.205

4.  Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.

Authors:  Koushi Hidaka; Tooru Kimura; Adam J Ruben; Tsuyoshi Uemura; Mami Kamiya; Aiko Kiso; Tetsuya Okamoto; Yumi Tsuchiya; Yoshio Hayashi; Ernesto Freire; Yoshiaki Kiso
Journal:  Bioorg Med Chem       Date:  2008-10-10       Impact factor: 3.641

5.  Chemical target validation studies of aminopeptidase in malaria parasites using alpha-aminoalkylphosphonate and phosphonopeptide inhibitors.

Authors:  Eithne Cunningham; Marcin Drag; Pawel Kafarski; Angus Bell
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

6.  Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.

Authors:  Roberta Spaccapelo; Chris J Janse; Sara Caterbi; Blandine Franke-Fayard; J Alfredo Bonilla; Luke M Syphard; Manlio Di Cristina; Tania Dottorini; Andrea Savarino; Antonio Cassone; Francesco Bistoni; Andrew P Waters; John B Dame; Andrea Crisanti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

7.  HIV treatments have malaria gametocyte killing and transmission blocking activity.

Authors:  Charlotte V Hobbs; Takeshi Q Tanaka; Olga Muratova; Jillian Van Vliet; William Borkowsky; Kim C Williamson; Patrick E Duffy
Journal:  J Infect Dis       Date:  2013-03-28       Impact factor: 5.226

8.  Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete.

Authors:  Fengwu Li; Kailash P Patra; Charles A Yowell; John B Dame; Karen Chin; Joseph M Vinetz
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

9.  Catestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum.

Authors:  Aziza Akaddar; Cécile Doderer-Lang; Melissa R Marzahn; François Delalande; Marc Mousli; Karen Helle; Alain Van Dorsselaer; Dominique Aunis; Ben M Dunn; Marie-Hélène Metz-Boutigue; Ermanno Candolfi
Journal:  Cell Mol Life Sci       Date:  2009-12-31       Impact factor: 9.261

10.  Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.

Authors:  Shoba Subramanian; Markus Hardt; Youngchool Choe; Richard K Niles; Eric B Johansen; Jennifer Legac; Jiri Gut; Iain D Kerr; Charles S Craik; Philip J Rosenthal
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.